Nazione: Malta
Lingua: inglese
Fonte: Medicines Authority
Viatris Healthcare Limited Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN , Ireland
C08DA01
VERAPAMIL HYDROCHLORIDE 240 mg
PROLONGED-RELEASE TABLET
VERAPAMIL HYDROCHLORIDE 240 mg
POM
CALCIUM CHANNEL BLOCKERS
Authorised
2023-10-31
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ISOPTIN SR 240MG® PROLONGED-RELEASE TABLETS (VERAPAMIL HYDROCHLORIDE) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See Section 4. WHAT IS IN THIS LEAFLET 1. What Isoptin is and what it is used for 2. What you need to know before you take Isoptin 3. How to take Isoptin 4. Possible side effects 5. How to store Isoptin 6. Contents of the pack and other information 1. WHAT ISOPTIN IS AND WHAT IT IS USED FOR Isoptin tablets belong to a group of medicines called calcium channel blockers. Calcium channel blockers change the amount of calcium getting into the muscle cells in your heart and blood vessels. This can change the strength and speed with which your heart beats. It also opens up the blood vessels so blood can be pumped around the body more easily. This helps more oxygen to get to your heart muscle and can lower your blood pressure. Isoptin tablets are used to treat hypertension (high blood pressure) and to prevent angina (chest pain) attacks. The active ingredient in Isoptin tablets is verapamil hydrochloride. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ISOPTIN DO NOT TAKE ISOPTIN IF: • you are sensitive (allergic) to verapamil or any of the ingredients in the tablets? (See Section 6) • your blood pressure is extremely low as a result of heart problems (such as during shock) • you have recently had a heart attack (within the last 7 days) • you have heart failure or second or third degree heart block (impaired nerve signal in the heart – causing a very slow heart Leggi il documento completo
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Isoptin SR 240 mg Prolonged-Release Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each Isoptin Prolonged-Release Tablet contains 240 mg Verapamil Hydrochloride. Excipients with known effect: Each prolonged release tablet contains 37.1 mg sodium. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Prolonged-release film-coated tablet. The oblong tablets are film-coated and light green colour, with a breakline on both sides and the Knoll logo on one side. The tablets can be divided into equal halves but must not be crushed or chewed. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Mild to moderate hypertension and coronary heart disease, i.e. prophylaxis of myocardial ischaemia, angina pectoris. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The dose of verapamil hydrochloride should be adjusted individually in accordance with the severity of disease. Long-standing clinical experience shows that the average daily dose in all indications is between 240 mg and 360 mg. The daily dose should not exceed 480 mg on a long-term basis, although a higher dose may be used for a short period. There is no limitation on the duration of use. Verapamil hydrochloride should not be discontinued abruptly after long-term use. It is recommended to taper the dosage. Verapamil hydrochloride 40mg mg tablets should be used for patients likely to display a satisfactory response to low doses (e.g. patients with hepatic dysfunction or elderly patients). For patients requiring higher dosages (e.g., 240 mg to 480 mg verapamil hydrochloride per day), formulations with a more suitable active drug content should be used. Adults _Hypertension: _ The adult dose is one tablet (240 mg) in the morning, increasing if necessary after one week to 240 mg in the morning and 240 mg in the evening, with an interval of 12 hours. In elderly patients, the initial dose is half a tablet (120 mg) in the morning, increasing by 120 mg increments at weekly intervals according t Leggi il documento completo